Breast Cancer Research and Treatment
July 2016, Volume 158, Issue 1, pp 91–97
Weekly paclitaxel with trastuzumab and pertuzumab in patients with HER2-overex
pressing metastatic breast cancer: overall survival and updated progression-fr
ee survival results from a phase II study
Email:seeoutony@gmail.com
感激不盡
--
※ 發信站: 批踢踢實業坊(ptt.cc), 來自: 111.83.224.234
※ 文章網址: https://www.ptt.cc/bbs/medstudent/M.1494574830.A.083.html